Meihua International Medical Technologies Co., Ltd. (MHUA)
USD 0.29
(-8.38%)
USD 0.29
(-8.38%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 25.07 Million USD | 0.72% |
| 2022 | 24.89 Million USD | -17.14% |
| 2021 | 30.04 Million USD | 40.98% |
| 2020 | 21.31 Million USD | 57.33% |
| 2019 | 13.54 Million USD | -24.56% |
| 2018 | 17.95 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 29.59 Million USD | 0.0% |
| 2024 Q1 | 29.59 Million USD | 18.0% |
| 2023 Q4 | 25.07 Million USD | 0.0% |
| 2023 Q1 | 23.22 Million USD | -6.73% |
| 2023 FY | 25.07 Million USD | 0.72% |
| 2023 Q3 | 25.07 Million USD | 7.99% |
| 2023 Q2 | 23.22 Million USD | 0.0% |
| 2022 Q4 | 24.89 Million USD | 0.0% |
| 2022 Q3 | 24.89 Million USD | 6.82% |
| 2022 FY | 24.89 Million USD | -17.14% |
| 2022 Q2 | 23.3 Million USD | 0.0% |
| 2022 Q1 | 23.3 Million USD | -22.42% |
| 2021 Q1 | 23.89 Million USD | 12.09% |
| 2021 FY | 30.04 Million USD | 40.98% |
| 2021 Q4 | 30.04 Million USD | 3.29% |
| 2021 Q2 | 23.89 Million USD | 0.0% |
| 2021 Q3 | 29.08 Million USD | 21.76% |
| 2020 Q3 | 21.31 Million USD | 2.92% |
| 2020 Q4 | 21.31 Million USD | 0.0% |
| 2020 Q2 | 20.7 Million USD | 0.0% |
| 2020 Q1 | 20.7 Million USD | 52.86% |
| 2020 FY | 21.31 Million USD | 57.33% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 13.54 Million USD | -24.56% |
| 2019 Q4 | 13.54 Million USD | 0.0% |
| 2019 Q3 | 13.54 Million USD | 0.0% |
| 2018 FY | 17.95 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 80.191% |
| AngioDynamics, Inc. | 112.08 Million USD | 77.626% |
| AtriCure, Inc. | 147.76 Million USD | 83.029% |
| Avinger, Inc. | 19.97 Million USD | -25.563% |
| Azenta, Inc. | 351.22 Million USD | 92.86% |
| BioLife Solutions, Inc. | 75.05 Million USD | 66.586% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 99.39% |
| Daxor Corporation | 858.75 Thousand USD | -2820.2% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -53.736% |
| Femasys Inc. | 9.4 Million USD | -166.69% |
| GlucoTrack, Inc. | 1.7 Million USD | -1368.235% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 60.994% |
| Hologic, Inc. | 4.02 Billion USD | 99.377% |
| ICU Medical, Inc. | 2.25 Billion USD | 98.888% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 98.773% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -209.323% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | 48.694% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -3699.982% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -3699.982% |
| Masimo Corporation | 1.67 Billion USD | 98.504% |
| Microbot Medical Inc. | 3.82 Million USD | -555.448% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 97.767% |
| Nephros, Inc. | 3.5 Million USD | -615.885% |
| NovoCure Limited | 783.63 Million USD | 96.8% |
| NEXGEL, Inc. | 4.78 Million USD | -423.647% |
| NEXGEL, Inc. | 4.78 Million USD | -423.647% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 70.996% |
| OraSure Technologies, Inc. | 52.17 Million USD | 51.935% |
| Pro-Dex, Inc. | 23.34 Million USD | -7.43% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -52.502% |
| Predictive Oncology Inc. | 6.14 Million USD | -308.064% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -266.373% |
| QuidelOrtho Corporation | 3.55 Billion USD | 99.295% |
| Repligen Corporation | 853.2 Million USD | 97.061% |
| Sanara MedTech Inc. | 29.28 Million USD | 14.362% |
| STAAR Surgical Company | 102.73 Million USD | 75.591% |
| Sharps Technology, Inc. | 3.85 Million USD | -550.521% |
| Utah Medical Products, Inc. | 7.14 Million USD | -250.979% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 99.385% |
| Jin Medical International Ltd. | 8.92 Million USD | -181.0% |